Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accommodate, Adhera, alongside, anaemia, ANPRM, antiphospholipid, APS, arithmetic, ARVO, Aspire, Atrin, bid, bidder, bona, BPDAI, carrier, cicatrizing, CliveRichardson, coagulation, conditionand, CT, database, DIC, dog, downstream, elevated, endothelium, escrow, fatality, fell, fide, float, gateway, GvHD, haemapoietc, haemolytic, hematopietic, HHS, HM, HRSA, HSCT, HUS, inflamed, injector, intentionally, intravascular, involuntarily, IPI, judge, leukotrine, Library, lowest, Lubeck, malignant, marrow, mometasone, motion, multilateral, Newark, nil, Nomacopan, Nonproprietary, outlier, PBM, pen, perspective, pig, pilot, poster, pronounced, Puglisi, purportedly, reconstituted, Renumeration, resTORbio, rulemaking, Sc, session, Spring, statutorily, stem, television, theoretically, thirteen, thrombocytopaenia, thrombocytopaenic, TTP, uncover, undertook, upfront, uraemic, USD, Vancouver, viscosity, Vision, VWAP, wider, Zileuton
Removed:
acquiring, allocation, amounting, assumption, biology, copying, DC, designing, device, exchanged, floor, footnote, freestanding, Galderma, golden, heart, immunology, irrevocable, Jersey, Jumpstart, launch, nonbinding, opt, parachute, ratchet, repaid, scheduled, supplement, timeframe, toxicology, Washington, West, whichever
Filing tables
Filing exhibits
AKTX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Akari Therapeutics, Plc.
London, United Kingdom
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-198109 and No. 333-207444), and the Registration Statement on Form F-3 (No. 333-220052) of Akari Therapeutics, Plc., of our report dated April 23, 2019, relating to the consolidated financial statements, which appears in this Form 20-F.
/s/ BDO USA, LLP
New York, New York
April 23, 2019